AGED Diagnostics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Later Stage VC
- Investors
-
13
AGED Diagnostics General Information
Description
Operator of a biotechnology company intended to create a non-invasive test for liver disease. The company focuses on using transcriptional genetic analysis to identify the patterns of early tumorigenesis, enabling medical researchers to obtain an accurate depiction of their patients' health.
Contact Information
Website
www.ageddiagnostics.comCorporate Office
- 6720A Rockledge Drive
- Bethesda, MD 20817
- United States
Corporate Office
- 6720A Rockledge Drive
- Bethesda, MD 20817
- United States
AGED Diagnostics Timeline
AGED Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 20-Jul-2026 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 20-Oct-2025 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 14-Aug-2025 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 23-Dec-2024 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 28-Sep-2023 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 01-Jan-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 07-Dec-2021 | $20K | $30K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 08-Jul-2020 | $10K | $10K | Completed | Generating Revenue |
AGED Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Convertible Pref |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
AGED Diagnostics Patents
AGED Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4750919-A1 | Systems and methods for methylation analysis of liver disease | Pending | 25-Jul-2023 | ||
| WO-2025024670-A1 | Systems and methods for methylation analysis of liver disease | Inactive | 25-Jul-2023 | ||
| EP-4377480-A2 | Methods and compositions for treating liver cancer and liver disease | Inactive | 30-Jul-2021 | ||
| EP-4377480-A4 | Methods and compositions for treating liver cancer and liver disease | Inactive | 30-Jul-2021 | ||
| US-20250027164-A1 | Methods and compositions for treating liver cancer and liver disease | Pending | 30-Jul-2021 | C12Q1/6886 |
AGED Diagnostics Signals
AGED Diagnostics Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Plug and Play | Accelerator/Incubator | |||
| Central Texas Angel Network | Angel Group | Minority | ||
| DMV Angel Group | Angel Group | Minority | ||
| Gloucester Ventures | Venture Capital | Minority | ||
| Intelligence Ventures | Venture Capital | Minority |
AGED Diagnostics FAQs
-
When was AGED Diagnostics founded?
AGED Diagnostics was founded in 2018.
-
Where is AGED Diagnostics headquartered?
AGED Diagnostics is headquartered in Bethesda, MD.
-
What is the size of AGED Diagnostics?
AGED Diagnostics has 5 total employees.
-
What industry is AGED Diagnostics in?
AGED Diagnostics’s primary industry is Laboratory Services (Healthcare).
-
Is AGED Diagnostics a private or public company?
AGED Diagnostics is a Private company.
-
What is AGED Diagnostics’s current revenue?
The current revenue for AGED Diagnostics is .
-
How much funding has AGED Diagnostics raised over time?
AGED Diagnostics has raised $3.54M.
-
Who are AGED Diagnostics’s investors?
Plug and Play, Central Texas Angel Network, DMV Angel Group, Gloucester Ventures, and Intelligence Ventures are 5 of 13 investors who have invested in AGED Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process